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S-protein is an abundant plasma protein which has recently been shown to be identical to vitronectin and 
serum spreading factor [(1985) EMBO J. 4, 31X+-3157]. It therefore has multiple binding sites for terminal 
complement complexes, thrombin-antithrombin III, heparin, and a specific cell receptor. In this report a 
structural and sequence homology with hemopexin is described which suggests that the principle function 
of S-protein could be as a scavenging molecule, clearing spent complement and coagulation complexes from 
the circulation 
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1. INTRODUCTION 
S-protein, vitronectin and serum spreading fac- 
tor all refer to the same 75 kDa protein of plasma, 
the different names reflecting the ways in which 
the protein was discovered. S-protein stands for 
‘complement membrane-site quivalent’ [Z] and is 
derived from the ability of S-protein to bind to 
nascent erminal complement complexes generated 
in the fluid phase [2-51, thus preventing mem- 
brane integration and protecting bystander cells 
from lysis [2-4,6]. The same protein was isolated 
from serum by its ability to bind to glass beads [7] 
and was therefore called vitronectin [8,9]. Binding 
studies showed that the protein had fragments 
capable of binding to heparin [lo] and cell surface 
receptors [ 11,121, and when coated on plastic or 
glass surfaces has a cell-spreading activity 1131. 
These studies suggested that vitronectin/serum 
spreading factor might function as a cell adhesion 
molecule of the extracellular matrix, although its 
abundance in plasma is not explained on this 
hypothesis. S-protein also forms stable complexes 
with thrombin-~tithrombin III [14,15], sug- 
gesting a further possible role in the coagulation 
pathway. The homology reported here between S- 
protein and hemopexin raises the possibility that S- 
protein functions as a scavenging molecule for in- 
active terminal complement and coagulation com- 
plexes. This hypothesis can account for its multiple 
binding activities and high concentration in 
plasma. 
2. RESULTS AND DISCUSSION 
Comparison of the S-protein amino acid se- 
quence with the protein sequence data library of 
the National Biomedical Research Foundation us- 
ing the algorithm developed by Lipman and Pear- 
son [16] suggested a homology between the central 
portion of S-protein and hemopexin. This 
homology had presumably not been noticed 
previously because 3 bases missing in the vitronec- 
tin cDNA sequence [I ,121 cause a reading frame 
shift in one of the best regions of homology. 
Published comparisons of the hemopexin sequence 
with itself have suggested that the two halves of the 
protein are related 117,181 and that 5 structurally 
related segments can be discerned in each half of 
the molecule [IQ Comparisons of S-protein with 
itself and with hemopexin show that S-protein also 
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contains 10 repeats although, like hemopexin [ 181, 
some of these repeats are closer to the consensus 
than others. 
Fig.1 shows the internal homology found by 
comparing the sequence of S-protein with itself on 
the basis of residue physical parameters [ 191 which 
are important for protein folding. All values at 
each residue position along one axis of the matrix 
comparison table have been summed and 
smoothed according to the method of Argos [ 181. 
This method emphasises repeating structures and 
gives an estimate of the sequence coordinates of 
each repeat. Six major peaks can be seen in this 
figure (numbered 3-7, lo), each followed by a sub- 
sidiary peak arising as a result of homology being 
found more strongly within the second half of 
some repeats. In addition, minor peaks can be seen 
before peak 3, and in the gap between peaks 7 and 
10, suggesting that weakly related sequences may 
be present in the other 4 positions giving a total of 
10 repeats as is found in hemopexin. All of the ma- 
jor self-homologous egments of the S-protein se- 
quence show structural homology with most of the 
hemopexin repeats (fig.2). No overall homology 
could be discerned, however (which would give rise 
to a continuous diagonal line from bottom left to 
top right), suggesting that considerable divergence 
of the two proteins must have occurred. 
Using the combined information of figs 1 and 2 
it was possible to determine the precise starting 
positions of the 6 major homologous regions of S- 
protein. These regions shared the same consensus 
sequence as that already determined for hemopex- 
in [ 181, having a conserved glycine residue in a 
hydrophobic environment at the amino-terminal 
end, and an aspartic acid followed by two alanine 
residues at the carboxy-terminal end (marked with 
an asterisk in fig.3). The remaining 4 regions cor- 
responded to the somatamedin B domain, the 
heparin-binding site, and two other regions 
without described functional properties. In each of 
these regions sequences approximating the consen- 
sus sequence could be found by visual inspection 
and are included in fig.3. These sequences give rise 
to the small peaks of self-homology in fig.1. It is 
interesting to note that the somatomedin B and 
heparin-binding site occupy exactly one repeat in 
this alignment, and also that the cell attachment 
site (box, fig.3) and two known cleavage points of 
the molecule (arrows, fig.3), which are likely to be 
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Fig. l(Top). Self-homology of S-protein determined by 
scoring all possible comparisons of sequence spans 15 
residues in length on the basis of 6 physical parameters 
important for protein folding [30] and the Dayhoff 
relatedness odds matrix [31-331. Values greater than 3.5 
SD above the mean of the comparison matrix were 
summed at each sequence position as described [181. The 
peaks corresponding to the aligned sequences in fig.3 are 
numbered l-10. 
Fig.Z(Bottom). Predicted structural homology between 
S-protein and hemopexin. The two sequences were 
compared as described in fig.1 a total of 16 times using 
windows of comparison between 5 and 20 residues in 
length. Values in each comparison matrix which were 4 
SD or more above the mean matrix value are displayed 
as diagonal lines the length of the respective windows. 
Divisions marked inside the axes show the starting 
residues of the aligned sequences in fig.3. 
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S-PROTEIN 
---------DQESCKGRCTEGF-----------NVDKKCQCDELCSYYQSCCTDYTAECKPQV~FT 
---MPEDEYTVYDDPGEEK------------------ NNATVHEQVGGPSLTSDLQAQSKGNPEQTPVLK 
EEEAPAPEVGASKPEGIDSR------- PETLHPGRPQPPAEEELCS-G--KPFDAFTDLK---------- 
-------NGSLFAFRGQYCY -------ELDEKAVRPGYPKLIRDVW-GIEGPIDAAF------------- 
--TRINCQGKTYLFKGNQYWRF-------EDGVLDPDYPR~ISDGFDGIPDNVDAALAL----------- 
PAHSYSGRERVYFFKGKQYW---EYQFQHQPSQEECEGSSLSAVFEHFAMMQRDSWEDIFEL-------- 
-------LFWGRTSAGTRQP-------------------QFISRDWHGVPGQVD 
i4 
MAGRIYISGMAPFfb 
-SLTKKQRFRHRNRKGYRSQ----- --------------RGHSRGRNQNSRRPS MWL----------- 
_---_SLFSS~ESNLGANNY__-----_----~--___--___DDY__---RMDWLVPA----_----_- 
---TCEPIQSVFFFSGDKYYRV---------- --NLRTRRVDTVDPPYPRSIAQYWLGCPAPGHL----- 
HAEMOPEXIN 
------TPLPPTSAHGNVAE------------GETKPDPDVTERCSDGW--SFDATT------------- 
----LDDNGTMLFFKGEFVW------------KSHKWDRELISERWKNFPSPVDAAF------------- 
----RQGHNSVFLIKGDKVWVY-------PPEKKEKGYPKLLQDEFPGIPSPLDAAVECHRGEC------ 
------QAEGVLFFQGDREWFW---------- --DLATGTMKERSWPAVGN-CSSAL------------- 
-----R~LGRYYCFQGNQFLRF-------------DPVRGEVPPRYPR--DVRDYFMPCP---------- 
-----GRGHGHRNGTGHG;S __------_---~-THHGP~YM-RCSPHL-_VLSALT~-VLSALT-~~~~-~~~~~~- 
----SDNHGATYAFSGTHYWRL--------DTSRDGWHSWPIAHQWPQGPSAVDAAF------------- 
-----SWEEKLYLVQG'rQVYVFLTKGGYTLVSGYPKRLEKEVG'TPHGIILDSVDAAFICP---------- 
------GSSRLHIMAGRRLWWL-----------DLKSGAQATWTELPWPHEKVDGALCMEKSLGPNSC-- 
----SANGPGLYLIHGPNLYCY------------SDVEKLNAAKALPQPQ~-VTSLLGCTH--------- 
++++ * ++ i-t +***t 
Fig.3. Aligned repeat unit in S-protein and hemopexin. The 10 related sequences of S-protein and hemopexin are shown 
aligned by the conserved Gly and Asp residues at either end of the repeat. Exposed cleavage sites in S-protein are 
indicated with arrows, the ceil attachment site by a box, and putative sites for N-linked oligosaccharide attachment are 
shown underlined. Repeat 1 of the S-protein is the somatomedin B fragment, and repeat 8 the heparin-binding site. 
Amino acids occurring 10 or more times in the same position are shown under the aligned sequences with an asterisk, 
those of conserved character according to the scheme: (P,G); (T,S); (K,R); (D,E,Q,N); (A,V,I,C,M,L,H,F,Y,N); are 
shown by a + . 
exposed regions, lie in the same relative position in 
the repeat. 
Despite the evidence for a duplication of se- 
quence in hemopexin only two of its disulphide 
bonds are conserved [171. These connect a cysteine 
in the first and sixth repeat of the molecule 
(residues 27 and 234) to one in the fifth and tenth 
repeat (residues 208 and 433). In S-protein the 
carboxy-terminal fragment cleaved by trypsin at 
residue 380 [1,20] is not released unless the 
molecule is reduced [ 14,20-221, indicating that it is 
held by a disulphide bond. One of the 2 cysteine 
residues in this fragment lies in the tenth repeat of 
S-protein and in the same relative position as cys- 
teines 208 and 433 of hemopexin. It will be in- 
teresting to determine if this cysteine is connected 
across the second half of the molecule to the cys- 
teine residue in the sixth repeat. There is unfor- 
tunately no obvious similarity between the position 
of the cell binding and heparin-binding sites of S- 
protein and histidine residues of hemopexin which 
might be involved in heme binding. 
S-protein and hemopexin are related in several 
ways. Both are glycoproteins of similar M,, syn- 
thesised in the liver, which are present at high con- 
centration in plasma. Both molecules form stable 
complexes with inactive plasma proteins which 
have to be cleared from the circulation. Both have 
cell binding sites, although only S-protein has the 
Arg-Gly-Asp tripeptide common to fibrinogen, 
fibronectin, and Von Willebrand factor [ 11,23,24]. 
Finally, both proteins can undergo conformational 
changes to expose new binding sites, for a cell sur- 
face receptor in the case of hemopexin [25,26], and 
for heparin-like molecules in the case of S-protein 
[27]. Heparin binding could account for the S- 
protein interaction with thrombin-antithrombin 
III, since excess heparin inhibits S-protein binding 
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in this reaction [ 151, and excess S-protein abolishes 
the heparin stimulation of antithrombin [21]. Lit- 
tle is known about the interaction of terminal com- 
plement complexes with S-protein, both 
hydrophobic [4,6] and hydrophilic [ 141 interac- 
tions having been proposed. However, it is possi- 
ble that complement component C9 could present 
a heparin-like site since it contains a highly 
negatively charged cysteine-rich domain bearing 
homology to the LDL receptor [28] which is 
known to bind its ligand in a way which is com- 
petitively inhibited by heparin [29]. 
The homology reported here now suggests that 
both molecules are members of the same gene 
family. These similarities raise the possibility that 
S-protein might have a scavenging role, like that of 
hemopexin, but specific for spent complexes of the 
complement and coagulation pathways. In this 
way the multiple binding properties of the 
molecule can be accounted for. The previously 
described cell spreading activity of the protein may 
simply be a result of the assay system used, glass 
and plastic surfaces exposing the cell attachment 
site(s) in a similar manner to terminal complement 
and thrombin-antithrombin III complexes in viva. 
Experiments are presently in progress to test this 
hypothesis. 
S-protein has been given a number of names ac- 
cording to how it was first described (S-protein, 
vitronectin, serum spreading factor, and protein-X 
[15,22]). Now that its genealogy has been found 
perhaps it should be renamed ‘heparopexin’ ac- 
cording to its family name (pexin) and its principle 
ligand (heparin-like molecules). 
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